Maximilian A.K. Magulye is an Immunologist, Clinical Microbiologist, Genomics Scientist and academic affiliated with Makerere University College of Health Sciences in Uganda, where he has been contributing to health research since 2021. He obtained his academic qualification from the oldest and premier universities in East Africa. He is a graduate of the University of Dar-es-Salaam, Tanzania (Undergraduate degree) and Makerere University, Uganda (Postgraduate degree). In 2021, he obtained special training in Vaccinology from the University of Oxford, UK and Metagenomics from the University of California, Berkeley, USA in 2022.
His research interests are infection/Pathogen biology, Host-pathogen interactions, Pathogen OMICS and antimicrobial resistance. He is the principal investigator of the study “Genomics of multidrug resistant Klebsiella pneumoniae isolates from Mulago Referral Hospital in Uganda”. He is employing whole genome sequencing technology (WGS) in exploring the mechanisms of virulence and antimicrobial resistance in priority bacterial pathogens. He continues to be a leading voice in the discourse on public health challenges in East Africa and beyond, advocating for improved and cutting-edge research initiative to combat antimicrobial resistance.
He has published a considerable number of articles in international peer-reviewed scientific journals. In addition, he is a reviewer in a journal, New Microbes and New Infections.
Maximilian A.K. Magulye is an Immunologist, Clinical Microbiologist, Genomics Scientist and academic affiliated with Makerere University College of Health Sciences in Uganda, where he has been contributing to health research since 2021. He obtained his academic qualification from the oldest and premier universities in East Africa. He is a graduate of the University of Dar-es-Salaam, Tanzania (Undergraduate degree) and Makerere University, Uganda (Postgraduate degree). In 2021, he obtained special training in Vaccinology from the University of Oxford, UK and Metagenomics from the University of California, Berkeley, USA in 2022.
His research interests are infection/Pathogen biology, Host-pathogen interactions, Pathogen OMICS and antimicrobial resistance. He is the principal investigator of the study “Genomics of multidrug resistant Klebsiella pneumoniae isolates from Mulago Referral Hospital in Uganda”. He is employing whole genome sequencing technology (WGS) in exploring the mechanisms of virulence and antimicrobial resistance in priority bacterial pathogens. He continues to be a leading voice in the discourse on public health challenges in East Africa and beyond, advocating for improved and cutting-edge research initiative to combat antimicrobial resistance.
He has published a considerable number of articles in international peer-reviewed scientific journals. In addition, he is a reviewer in a journal, New Microbes and New Infections.